Mycobacterium Infections, Nontuberculous
Information
- Disease name
- Mycobacterium Infections, Nontuberculous
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04922554 | Active, not recruiting | Phase 2 | Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc) | October 15, 2021 | July 2024 |
| NCT02340897 | Completed | Diagnostic Accuracy of Nontuberculous Mycobacterial Lung Disease Based on Chest CT | December 2014 | March 2015 | |
| NCT02344004 | Completed | Phase 3 | Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone | May 27, 2015 | April 3, 2019 |
| NCT01315236 | Completed | Phase 2 | Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria | April 19, 2012 | June 18, 2015 |
| NCT04677543 | Completed | Phase 3 | Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex | December 22, 2020 | May 9, 2023 |
| NCT03038178 | Completed | Phase 2 | Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease | October 2016 | December 31, 2019 |
| NCT03421743 | Completed | Phase 2 | Pilot Trial of Inhaled Molgramostim in Nontuberculous Mycobacterial (NTM) Infection | March 1, 2018 | January 13, 2020 |
| NCT02832843 | Completed | Genome-Wide Association Study in Patients With Nontuberculous Mycobacterial Lung Disease | July 11, 2016 | October 3, 2019 | |
| NCT06418711 | Not yet recruiting | Phase 3 | ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension | June 2024 | December 1, 2028 |
| NCT04677569 | Recruiting | Phase 3 | Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex | April 1, 2021 | August 21, 2023 |
| NCT06266442 | Recruiting | M. Avium WGS During Mav-PD Treatment | May 13, 2024 | September 2026 | |
| NCT04154826 | Terminated | Phase 2 | Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease | November 30, 2020 | March 30, 2024 |
| NCT03597347 | Terminated | Phase 2 | Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection | June 20, 2019 | October 2, 2020 |
| NCT02355015 | Unknown status | A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections | March 2014 | December 2020 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009165